2026 NPPES data Low Vision Rehabilitation Optometrist NPI 1518950799 O.D.
Verify on CMS →

CHARLES HOLLANDER, O.D.

Low Vision Rehabilitation Optometrist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
187
Medicare Part D claims · 69 beneficiaries · Low Vision Rehabilitation Optometrist avg: 296
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
97.5/100
▲ 14 pts above national avg 83.1 · [object Object]
Industry payments
$329.28
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CHARLES HOLLANDER, O.D. reported a CMS MIPS final score of 97.5/100 — above the 83.1 national average — and filed 187 Medicare Part D claims in 2023.

97.5/100
MIPS score · +14 vs avg
187
Part D claims, 2023
67%
generic prescribing
$329.28
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHARLES HOLLANDER, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

98 Top 15% higher than 85% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about CHARLES HOLLANDER, O.D.?

High performer (top quartile)

NPI registry status

Active

Issued 08/23/2005

NPI 1518950799

Primary specialty

Low Vision Rehabilitation Optometrist

Rare

299 US NPIs in this specialty

Medicare Part D claims

187 37% vs specialty avg

2023 prescription claims

Specialty avg: 296

MIPS final score

97.5/100 14.400000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Low Vision Rehabilitation Optometrist compares to other specialties among New York providers

New York providers

Low Vision Rehabilitation Optometrist share within New York

1. Low Vision Rehabilitation Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Low Vision Rehabilitation Optometrist share within New York

Medicare quality performance — MIPS

CHARLES HOLLANDER, O.D.'s 2023 MIPS final score plotted against the Low Vision Rehabilitation Optometrist national average

High performer (top quartile)
MIPS Final Score
97.5/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Low Vision Rehabilitation Optometrist) — 97.5/100 vs national avg 83.1

0%100%National avg83%97.5%
MIPS final score (Low Vision Rehabilitation Optometrist) — 97.5/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHARLES HOLLANDER, O.D. appears in the CMS NPPES registry as a Low Vision Rehabilitation Optometrist provider holding O.D. credentials at 25 W 43RD ST, NEW YORK, NY, 10036, with a listed phone of (212) 921-1888. NPI 1518950799 was issued on 08/23/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HOLLANDER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 187 prescription claims written by this provider, covering 69 Medicare beneficiaries and totaling roughly $34K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 97.5/100 for the 2023 performance year (Quality 95), compared with the national average of 83.1.

Low Vision Rehabilitation Optometrist is a narrow specialty nationwide, with 299 enrolled providers across 39 states and an average of 296 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

25 W 43RD ST
NEW YORK, NY 10036

Provider Details

NPI 1518950799
Specialty Low Vision Rehabilitation Optometrist
Credentials O.D.
Gender Male
NPI Issued 08/23/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

97.5
Final Score
Avg: 83.1
95
Quality

Reporting: Individual

Hospital and facility affiliations

Facilities where CHARLES HOLLANDER, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

200 WEST OPTICS LLC
YONKERS, NY
SIGHT IMPROVEMENT CENTER INC.
NEW YORK, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHARLES HOLLANDER, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$329

Largest payer

SUN PHARMACEUTICAL INDUSTRIES INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to CHARLES HOLLANDER, O.D.. To verify CHARLES HOLLANDER, O.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

CHARLES HOLLANDER, O.D. — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 187 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

187
Total Claims
$34K
Total Drug Cost
69
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
227
Total Day Supply
5,587
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$31K
Generic Drug Cost
$3K

Patient Demographics

Average Patient Age
71.3 years
Avg HCC Risk Score
0.94
Gender Split
75% female / 25% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHARLES HOLLANDER, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
59
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
37
Restasis
Cyclosporine
18
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
17
Timolol Maleate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Low Vision Rehabilitation Optometrist Overview

How CHARLES HOLLANDER, O.D. fits within the Low Vision Rehabilitation Optometrist landscape nationally.

299
Low Vision Rehabilitation Optometrist Providers in US
39
States with Low Vision Rehabilitation Optometrist
296
Avg Claims per Provider

CHARLES HOLLANDER, O.D.'s 187 claims are below the specialty average of 296.

Nearby Low Vision Rehabilitation Optometrist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as HOLLANDER.

Compare Low Vision Rehabilitation Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHARLES HOLLANDER, O.D.'s specialty?
CHARLES HOLLANDER, O.D. specializes in Low Vision Rehabilitation Optometrist and practices in NEW YORK, New York. Credentials: O.D..
How much does CHARLES HOLLANDER, O.D. prescribe under Medicare Part D?
In 2023, CHARLES HOLLANDER, O.D. wrote 187 Medicare Part D claims totaling $34K in drug costs for 69 beneficiaries.
What is CHARLES HOLLANDER, O.D.'s Medicare quality score?
CHARLES HOLLANDER, O.D. has a CMS MIPS Final Score of 97.5/100 (Quality: 95). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CHARLES HOLLANDER, O.D. located?
CHARLES HOLLANDER, O.D. is located at 25 W 43RD ST, NEW YORK, NY, 10036. Phone: (212) 921-1888.
What is CHARLES HOLLANDER, O.D.'s NPI number?
CHARLES HOLLANDER, O.D.'s National Provider Identifier (NPI) is 1518950799, issued on 08/23/2005.
Does CHARLES HOLLANDER, O.D. prescribe more brand-name or generic drugs?
CHARLES HOLLANDER, O.D.'s prescribing is 33% brand-name and 67% generic drugs by claim count, with $31K in brand drug costs.
How many Low Vision Rehabilitation Optometrist providers are there in the US?
There are 299 Low Vision Rehabilitation Optometrist providers across 39 states in the US. The average Low Vision Rehabilitation Optometrist provider writes 296 Medicare Part D claims per year.
What drugs does CHARLES HOLLANDER, O.D. prescribe most often?
Based on 2023 Medicare Part D data, CHARLES HOLLANDER, O.D.'s most frequently prescribed drugs include Latanoprost, Neomycin-Polymyxin-Dexameth, Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHARLES HOLLANDER, O.D. accept Medicare?
CHARLES HOLLANDER, O.D. appears in CMS Medicare data with 187 Part D claims and 69 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHARLES HOLLANDER, O.D.'s credentials?
CHARLES HOLLANDER, O.D.'s NPI is 1518950799 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology